Bioequivalence Study of Bosiqing and ABILIFY Under Fasting/Fed Condition
Clinical trial NCT03232710 · UNKNOWN
Trial details
- NCT number
- NCT03232710
- Sponsor
- Chengdu Kanghong Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-26
- Primary completion
- 2018-04-30
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.